chr9-21802923-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001396040.1(MTAP):c.57C>G(p.Leu19Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0302 in 1,437,612 control chromosomes in the GnomAD database, including 1,054 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.024 ( 68 hom., cov: 28)
Exomes 𝑓: 0.031 ( 986 hom. )
Consequence
MTAP
NM_001396040.1 synonymous
NM_001396040.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0110
Genes affected
MTAP (HGNC:7413): (methylthioadenosine phosphorylase) This gene encodes an enzyme that plays a major role in polyamine metabolism and is important for the salvage pathway of both adenine and methionine. The encoded enzyme is deficient in many cancers. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2021]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 9-21802923-C-G is Benign according to our data. Variant chr9-21802923-C-G is described in ClinVar as [Benign]. Clinvar id is 1223355.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.011 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0758 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTAP | NM_002451.4 | c.33+142C>G | intron_variant | Intron 1 of 7 | ENST00000644715.2 | NP_002442.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0236 AC: 3513AN: 149060Hom.: 69 Cov.: 28 show subpopulations
GnomAD3 genomes
AF:
AC:
3513
AN:
149060
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0364 AC: 1731AN: 47538 AF XY: 0.0391 show subpopulations
GnomAD2 exomes
AF:
AC:
1731
AN:
47538
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0310 AC: 39939AN: 1288436Hom.: 986 Cov.: 32 AF XY: 0.0325 AC XY: 20465AN XY: 630306 show subpopulations
GnomAD4 exome
AF:
AC:
39939
AN:
1288436
Hom.:
Cov.:
32
AF XY:
AC XY:
20465
AN XY:
630306
show subpopulations
African (AFR)
AF:
AC:
77
AN:
25822
American (AMR)
AF:
AC:
258
AN:
18236
Ashkenazi Jewish (ASJ)
AF:
AC:
582
AN:
18512
East Asian (EAS)
AF:
AC:
3671
AN:
33024
South Asian (SAS)
AF:
AC:
4813
AN:
62094
European-Finnish (FIN)
AF:
AC:
1183
AN:
33952
Middle Eastern (MID)
AF:
AC:
81
AN:
3664
European-Non Finnish (NFE)
AF:
AC:
27367
AN:
1039732
Other (OTH)
AF:
AC:
1907
AN:
53400
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
2008
4015
6023
8030
10038
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0235 AC: 3508AN: 149176Hom.: 68 Cov.: 28 AF XY: 0.0254 AC XY: 1842AN XY: 72636 show subpopulations
GnomAD4 genome
AF:
AC:
3508
AN:
149176
Hom.:
Cov.:
28
AF XY:
AC XY:
1842
AN XY:
72636
show subpopulations
African (AFR)
AF:
AC:
185
AN:
40600
American (AMR)
AF:
AC:
309
AN:
14868
Ashkenazi Jewish (ASJ)
AF:
AC:
95
AN:
3456
East Asian (EAS)
AF:
AC:
409
AN:
4964
South Asian (SAS)
AF:
AC:
353
AN:
4602
European-Finnish (FIN)
AF:
AC:
370
AN:
10000
Middle Eastern (MID)
AF:
AC:
2
AN:
290
European-Non Finnish (NFE)
AF:
AC:
1732
AN:
67432
Other (OTH)
AF:
AC:
53
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
150
300
449
599
749
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
312
AN:
3466
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 21, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at